Business
Why the Aroa Biosurgery (ASX:ARX) share price is lifting today
The Aroa Biosurgery Ltd (ASX: ARX) share price is up 2.6% after the company shared positive news this morning. A new product from the soft-tissue regeneration company has received US Food and Drug Administration (FDA) clearance.
At the time of writing, the Aroa Biosurgery share price is trading at $1.17 after reaching an intraday high of $1.22 this morning.
Let’s look closer at the news of Aroa Biosurgery’s newest FDA cleared product.
Myriad Morcells
The company’s new product, Myriad Morcells, works to “kick start” a wound’s healing, according to Aroa Biosurgery vice president of research and clinical development Dr Barnaby…
-
Noosa News22 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours agoHelp to make recycling stick
-
Noosa News15 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business17 hours agoAlphabet’s stock looks like a brilliant buy right now